SC 13G/A | 2013-02-14 | Crede CG II, Ltd. | CELL THERAPEUTICS INC | 695,813 | 1.1% | EDGAR |
SC 13G/A | 2013-02-14 | TANG CAPITAL PARTNERS LP | CELL THERAPEUTICS INC | 0 | 0.0% | EDGAR |
SC 13G | 2012-11-13 | FMR LLC | CELL THERAPEUTICS INC | 8,034,958 | 12.8% | EDGAR |
SC 13G | 2012-10-09 | TANG CAPITAL PARTNERS LP | CELL THERAPEUTICS INC | 6,911,221 | 9.9% | EDGAR |
SC 13G/A | 2012-06-06 | Socius Capital Group, LLC | CELL THERAPEUTICS INC | 25,000,000 | 9.9% | EDGAR |
SC 13G | 2012-06-04 | Socius Capital Group, LLC | CELL THERAPEUTICS INC | 25,000,000 | 9.9% | EDGAR |
SC 13G/A | 2012-02-14 | Socius Capital Group, LLC | CELL THERAPEUTICS INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2012-02-13 | BlackRock Inc. | CELL THERAPEUTICS INC | 10,482,776 | 4.6% | EDGAR |
SC 13G | 2012-02-09 | BlackRock Inc. | CELL THERAPEUTICS INC | 10,386,223 | 5.4% | EDGAR |
SC 13G | 2011-01-24 | Socius Capital Group, LLC | CELL THERAPEUTICS INC | 87,029,396 | 9.7% | EDGAR |
SC 13D/A | 2009-04-28 | KOPIN MITCHELL P | CELL THERAPEUTICS INC | 22,551,319 | 4.8% | EDGAR |
SC 13D/A | 2009-04-27 | KOPIN MITCHELL P | CELL THERAPEUTICS INC | 28,354,834 | 6.0% | EDGAR |
SC 13D | 2009-04-23 | KOPIN MITCHELL P | CELL THERAPEUTICS INC | 33,504,923 | 7.1% | EDGAR |
SC 13G/A | 2009-02-10 | Enable Capital Management, LLC | CELL THERAPEUTICS INC | 25,640 | 0.1% | EDGAR |
SC 13G/A | 2009-02-10 | Enable Growth Partners L P | CELL THERAPEUTICS INC | 25,640 | 0.1% | EDGAR |
SC 13G/A | 2009-02-10 | Levine Mitchell S | CELL THERAPEUTICS INC | 25,640 | 0.1% | EDGAR |
SC 13G | 2008-10-06 | Enable Capital Management, LLC | CELL THERAPEUTICS INC | 2,051,195 | 10.0% | EDGAR |
SC 13G | 2008-10-06 | Enable Growth Partners L P | CELL THERAPEUTICS INC | 2,051,195 | 10.0% | EDGAR |
SC 13G | 2008-10-06 | Levine Mitchell S | CELL THERAPEUTICS INC | 2,051,195 | 10.0% | EDGAR |
SC 13G | 2008-08-25 | LEHMAN BROTHERS HOLDINGS INC | CELL THERAPEUTICS INC | 26,800 | 0.0% | EDGAR |